MIAMI, FL--(Marketwire - October 11, 2007) - Renhuang Pharmaceuticals, Inc. (or “the Company”) (OTCBB: RHGP), a leading integrated developer, manufacturer and distributor of a broad line of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products in the People’s Republic of China (PRC), is pleased to announce that is has received positive independent research coverage by Tony Carrion of Market Harmonics. Highlights from the report are presented below, and the full report can be accessed by clicking on the following link: http://www.thesubway.com/RHGP_Research_Summary-1.htm
